Planned sales, announced before they happen
0 trading plans running, 10 Form 144 notices for $111.1M
Plans running now
0
none adopted and not yet ended or expired
What FOXA's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Trading plans
Plans adopted or ended
| Insider | What | Date | Shares | Runs to | Reported in |
|---|---|---|---|---|---|
| John P. Nallen President and Chief Operating Officer |
Adopted 10b5-1 plan | Dec 2, 2025 | see filing | Aug 5, 2026 | 10-Q Feb 4, 2026 |
What the company wroteOn December 2, 2025, Lachlan K. Murdoch, the Company’s Executive Chair and Chief Executive Officer, and John P. Nallen, the Company’s President and Chief Operating Officer, each adopted a plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (a “Rule 10b5-1 plan”). Each plan provides for the future potential exercise of vested stock options (which are scheduled to expire in 2026) and the associated sale of up to (a) 952,384 shares of Class A Common Stock in the case of Mr. Murdoch’s plan and (b) 459,115 shares of Class A Common Stock in the case of Mr. Nallen’s plan. Each plan expires on August 5, 2026, or earlier either upon the completed sale of all shares subject to such plan or in certain other circumstances. Also on December 2, 2025, Mr. Murdoch adopted a Rule 10b5-1 plan for the future potential transfer by him of 175,372 shares of Class A Common Stock to a family trust, subject to certain conditions, which plan expires on August 5, 2026, or earlier in certain circumstances. | |||||
| Lachlan K. Murdoch Executive Chair and Chief Executive Officer |
Adopted 10b5-1 plan | Dec 2, 2025 | see filing | Aug 5, 2026 | 10-Q Feb 4, 2026 |
What the company wroteOn December 2, 2025, Lachlan K. Murdoch, the Company’s Executive Chair and Chief Executive Officer, and John P. Nallen, the Company’s President and Chief Operating Officer, each adopted a plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (a “Rule 10b5-1 plan”). Each plan provides for the future potential exercise of vested stock options (which are scheduled to expire in 2026) and the associated sale of up to (a) 952,384 shares of Class A Common Stock in the case of Mr. Murdoch’s plan and (b) 459,115 shares of Class A Common Stock in the case of Mr. Nallen’s plan. Each plan expires on August 5, 2026, or earlier either upon the completed sale of all shares subject to such plan or in certain other circumstances. Also on December 2, 2025, Mr. Murdoch adopted a Rule 10b5-1 plan for the future potential transfer by him of 175,372 shares of Class A Common Stock to a family trust, subject to certain conditions, which plan expires on August 5, 2026, or earlier in certain circumstances. | |||||
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 9, 2023.
Form 144
Notices of planned sales
| Filed | Seller | Shares | Value | Shares came from | 10b5-1 plan | Form 4 sales after |
|---|---|---|---|---|---|---|
| Mar 13, 2026 | Lachlan K. Murdoch Executive Chair and CEO |
462,380 | $26.7M | Issuance upon exercise of stock options pursuant to registration statement | adopted Dec 2, 2025 | none found |
| Mar 12, 2026 | Lachlan K. Murdoch Executive Chair and CEO |
247,257 | $14.3M | Issuance upon exercise of stock options pursuant to registration statement | adopted Dec 2, 2025 | none found |
| Mar 12, 2026 | John Nallen President and COO |
216,806 | $12.5M | Issuance upon exercise of stock options pursuant to registration statement | adopted Dec 2, 2025 | none found |
| Mar 11, 2026 | Lachlan K. Murdoch Executive Chair and CEO |
242,747 | $14.1M | Issuance upon exercise of stock options pursuant to registration statement | adopted Dec 2, 2025 | none found |
| Mar 11, 2026 | John Nallen President and COO |
242,309 | $14.1M | Issuance upon exercise of stock options pursuant to registration statement | adopted Dec 2, 2025 | none found |
| Dec 9, 2025 | Adam G. Ciongoli Chief Legal and Policy Officer |
29,897 | $2.1M | Issuance upon vesting of RSUs pursuant to registration statement | none given | none found |
| Nov 21, 2025 | Keith Rupert Murdoch Chairman Emeritus |
100,000 | $5.9M | Distribution | none given | none found |
| Nov 10, 2025 | Steven Tomsic Chief Financial Officer |
138,397 | $9.2M | Issuance upon exercise of stock options pursuant to registration statement | none given | none found |
| Nov 7, 2025 | Keith Rupert Murdoch Chairman Emeritus |
168,756 | $11.1M | Issuance upon exercise of stock options pursuant to registration statement | none given | none found |
| Oct 31, 2025 | PAUL D RYAN Director |
17,767 | $1.1M | Restricted stock vesting under a registered plan | none given | none found |
Show the other 2 notices
From the Form 144 XML filed with the SEC, since Oct 31, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.